Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis. International Ascites Club (Q34062215)

30 July 2017

1 reference

title

Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis. International Ascites Club (English)

1 reference

30 July 2017

Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis (English)

0 references

0 references

0 references

1 reference

P Ginès

Ginès P

2

1 reference

30 July 2017

V Arroyo

Arroyo V

1

1 reference

30 July 2017

3

A L Gerbes

Gerbes AL

1 reference

30 July 2017

Gentilini P

5

1 reference

30 July 2017

Laffi G

6

1 reference

30 July 2017

Ring-Larsen H

8

1 reference

30 July 2017

Schölmerich J

9

1 reference

30 July 2017

F J Dudley

4

1 reference

30 July 2017

T B Reynolds

7

1 reference

30 July 2017

language of work or name

English

0 references

publication date

1 January 1996

1 reference

30 July 2017

January 1996

0 references

published in

Hepatology

1 reference

30 July 2017

volume

23

1 reference

30 July 2017

issue

1

1 reference

30 July 2017

page(s)

164-176

1 reference

Peripheral arterial vasodilation hypothesis: a proposal for the initiation of renal sodium and water retention in cirrhosis.

30 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510230122

7 January 2021

Endothelins: multifunctional renal peptides

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510230122

7 January 2021

Hyperdynamic circulation in cirrhosis: a role for nitric oxide?

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510230122

7 January 2021

Plasma endothelin immunoreactivity in liver disease and the hepatorenal syndrome

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510230122

7 January 2021

Comparison of paracentesis and diuretics in the treatment of cirrhotics with tense ascites. Results of a randomized study

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510230122

7 January 2021

Refractory ascites: early experience in treatment with transjugular intrahepatic portosystemic shunt

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510230122

7 January 2021

Blockade of the hydroosmotic effect of vasopressin normalizes water excretion in cirrhotic rats

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510230122

7 January 2021

Therapeutic efficacy of the non-peptide AVP antagonist OPC-31260 in cirrhotic rats

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510230122

7 January 2021

Aquaretic effect of the kappa-opioid agonist RU 51599 in cirrhotic rats with ascites and water retention

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510230122

7 January 2021

Bacterial translocation in cirrhotic rats. Its role in the development of spontaneous bacterial peritonitis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510230122

7 January 2021

Tumor necrosis factor alpha and interleukin 6 plasma levels in infected cirrhotic patients

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510230122

7 January 2021

Spontaneous bacterial peritonitis in liver cirrhosis: treatment and prophylaxis.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510230122

7 January 2021

Norfloxacin prevents spontaneous bacterial peritonitis recurrence in cirrhosis: results of a double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510230122

7 January 2021

Selective intestinal decontamination prevents spontaneous bacterial peritonitis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510230122

7 January 2021

A European survey on the treatment of ascites in cirrhosis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510230122

7 January 2021

Chronic active hepatitis: the challenge for a new nomenclature

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510230122

7 January 2021

Renal sodium retention during upright posture in preascitic cirrhosis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510230122

7 January 2021

Hepatorenal disorders: role of the renin-angiotensin-aldosterone system

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510230122

7 January 2021

Hepatorenal disorders: role of the sympathetic nervous system

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510230122

7 January 2021

Elevated plasma norepinephrine concentrations in decompensated cirrhosis. Association with increased secretion rates, normal clearance rates, and suppressibility by central blood volume expansion.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510230122

7 January 2021

Total and renal sympathetic nervous system activity in alcoholic cirrhosis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510230122

7 January 2021

Increased Sympathetic Nervous Activity and the Effects of Its Inhibition with Clonidine in Alcoholic Cirrhosis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510230122

7 January 2021

Increased sympathetic outflow in cirrhosis and ascites: direct evidence from intraneural recordings

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510230122

7 January 2021

Splanchnic and renal elimination and release of catecholamines in cirrhosis. Evidence of enhanced sympathetic nervous activity in patients with decompensated cirrhosis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510230122

7 January 2021

Hepatic intestinal uptake and release of catecholamines in alcoholic cirrhosis. Evidence of enhanced hepatic intestinal sympathetic nervous activity

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510230122

7 January 2021

Pathophysiology of sodium retention and ascites formation in cirrhosis: role of atrial natriuretic factor

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510230122

7 January 2021

Antidiuretic hormone and the pathogenesis of water retention in cirrhosis with ascites

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510230122

7 January 2021

Temporal relationship between the impairment of free water excretion and antidiuretic hormone hypersecretion in rats with experimental cirrhosis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510230122

7 January 2021

Potential role of increased sympathetic activity in impaired sodium and water excretion in cirrhosis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510230122

7 January 2021

Evidence that renal prostaglandins are involved in renal water metabolism in cirrhosis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510230122

7 January 2021

Role of vasopressin in abnormal water excretion in cirrhotic patients

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510230122

7 January 2021

Increased gene expression of water channel in cirrhotic rat kidneys

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510230122

7 January 2021

Role of vasopressin in impaired water excretion in conscious rats with experimental cirrhosis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510230122

7 January 2021

Metabolic clearance rate of arginine vasopressin in patients with cirrhosis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510230122

7 January 2021

Renal neural activity in hepatorenal syndrome

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510230122

7 January 2021

Peripheral arterial vasodilatation: determinant of functional spectrum of cirrhosis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510230122

7 January 2021

Effects of lumbar sympathetic block on kidney function in cirrhotic patients with hepatorenal syndrome

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510230122

7 January 2021

Prostaglandins: Modulators of Renal Function and Pressor Resistance in Chronic Liver Disease*

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510230122

7 January 2021

Sympathetic nervous activity, renin-angiotensin system and renal excretion of prostaglandin E2in cirrhosis. Relationship to functional renal failure and sodium and water excretion

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510230122

7 January 2021

Urinary excretion of 6-keto-prostaglandin F1α, thromboxane B2 and prostaglandin E2 in cirrhosis with ascites

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510230122

7 January 2021

Immunohistochemical distribution of renal prostaglandin endoperoxide synthase and prostacyclin synthase: diminished endoperoxide synthase in the hepatorenal syndrome

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510230122

7 January 2021

Renal function abnormalities, prostaglandins, and effects of nonsteroidal anti-inflammatory drugs in cirrhosis with ascites. An overview with emphasis on pathogenesis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510230122

7 January 2021

Renal effects of natriuretic peptide receptor blockade in cirrhotic rats with ascites.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510230122

7 January 2021

Arteriolar vasodilation and the pathogenesis of the hyperdynamic circulation and renal sodium and water retention in cirrhosis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510230122

7 January 2021

Spironolactone: Disposition, Metabolism, Pharmacodynamics, and Bioavailability

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510230122

7 January 2021

Spironolactone pharmacokinetics and pharmacodynamics in patients with cirrhotic ascites

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510230122

7 January 2021

https://api.crossref.org/works/10.1002%2FHEP.510230122

1 reference

7 January 2021

A pathophysiological interpretation of unresponsiveness to spironolactone in a stepped-care approach to the diuretic treatment of ascites in nonazotemic cirrhotic patients

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510230122

7 January 2021

Interaction of prostaglandins with diuretics

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510230122

7 January 2021

Advantages of the new loop diuretic torasemide over furosemide in patients with cirrhosis and ascites. A randomized, double blind cross-over trial

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510230122

7 January 2021

Complications of diuretic therapy in hepatic cirrhosis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510230122

7 January 2021

Organization of hepatic nitrogen metabolism and its relation to acid-base homeostasis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510230122

7 January 2021

Compartmentalization of Ascites and Edema in Patients with Hepatic Cirrhosis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510230122

7 January 2021

Effectiveness of high-dose spironolactone therapy in patients with chronic liver disease and relatively refractory ascites

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510230122

7 January 2021

Spironolactone-Induced Hyperchloremic Acidosis in Cirrhosis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510230122

7 January 2021

Repeated paracentesis and i.v. albumin infusion to treat 'tense' ascites in cirrhotic patients. A safe alternative therapy.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510230122

7 January 2021

Total paracentesis associated with intravenous albumin management of patients with cirrhosis and ascites

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510230122

7 January 2021

Paracentesis with Intravenous Infusion of Albumin as Compared with Peritoneovenous Shunting in Cirrhosis with Refractory Ascites

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510230122

7 January 2021

Should portosystemic shunt be reconsidered in the treatment of intractable ascites in cirrhosis?

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510230122

7 January 2021

Combined Ascitic-Fluid and Furosemide Infusion in the Management of Ascites

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510230122

7 January 2021

Treatment of ascites by reinfusion of concentrated peritoneal fluid—a review of 318 procedures in 210 patients

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510230122

7 January 2021

Peritoneo-venous shunting for ascites

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510230122

7 January 2021

Efficacy and safety of the stepped care medical treatment of ascites in liver cirrhosis: a randomized controlled clinical trial comparing two diets with different sodium content

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510230122

7 January 2021

Transplantation of cadaveric kidneys from patients with hepatorenal syndrome. Evidence for the functionalnature of renal failure in advanced liver disease

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510230122

7 January 2021

Recovery from “Hepatorenal Syndrome” after Orthotopic Liver Transplantation

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510230122

7 January 2021

Renal failure in patients with cirrhosis of the liver. 3. Evaluation of intrarenal blood flow by para-aminohippurate extraction and response to angiotensin

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510230122

7 January 2021

Renal failure in the patient with cirrhosis. The role of active vasoconstriction

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510230122

7 January 2021

Systemic and Renal Hemodynamics in Oliguric Hepatic Failure: Effect of Volume Expansion*

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510230122

7 January 2021

Plasma renin level in hepatic cirrhosis. Relaton to functional renal failure

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510230122

7 January 2021

Sympathetic nervous activity and renal and systemic hemodynamics in cirrhosis: plasma norepinephrine concentration, hepatic extraction, and renal release

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510230122

7 January 2021

Relation of renal impairment and haemorrhagic diathesis to endotoxaemia in fulminant hepatic failure.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510230122

7 January 2021

Systemic and regional hemodynamics in patients with liver cirrhosis and ascites with and without functional renal failure.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510230122

7 January 2021

Clinical types and drug therapy of renal impairment in cirrhosis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510230122

7 January 2021

Incidence, predictive factors, and prognosis of the hepatorenal syndrome in cirrhosis with ascites

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510230122

7 January 2021

Diagnosis of functional kidney failure of cirrhosis with Doppler sonography: Prognostic value of resistive index

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510230122

7 January 2021

Renal impairment after spontaneous bacterial peritonitis in cirrhosis: Incidence, clinical course, predictive factors and prognosis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510230122

7 January 2021

Rapid diuresis in patients with ascites from chronic liver disease: the importance of peripheral edema

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510230122

7 January 2021

Peritoneovenous shunt in the management of the hepatorenal syndrome

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510230122

7 January 2021

Cirrhotic glomerulonephritis: incidence, morphology, clinical features, and pathogenesis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510230122

7 January 2021

Membranoproliferative Glomerulonephritis Associated with Hepatitis C Virus Infection

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510230122

7 January 2021

Hepatorenal syndrome without avid sodium retention

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510230122

7 January 2021

10.1053/JHEP.1996.V23.AJHEP0230164

Identifiers

DOI

1 reference

30 July 2017

10.1002/HEP.510230122

0 references

1 reference